Article

jdsupra.com on 2020-03-26 20:36

Clinical Trials During the COVID-19 Pandemic

In light of the COVID-19 pandemic, the Food and Drug Administration (“FDA”) issued recent non-binding guidance (“Guidance”) on the conduct of ongoing ...

Related news

FDA Issues Guidance on Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Final Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Guidance on Conducting Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Allow Sponsors to Modify the Conduct of Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Additional Guidance on the Conduct of Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Conduct of Clinical Trials During the COVID-19 Pandemic: Recommendations from FDA jdsupra.com
California , United States , Switzerland
Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic: Guidance for Industry, Investigators, and Institutional Review Boards jdsupra.com
California , United States , Switzerland
FDA Changes Position on Clinical Trials and Respirators During COVID-19 Crisis jdsupra.com
California , United States , Switzerland
FDA Updates its Guidance on Conducting Clinical Trials During COVID-19 Public Health Emergency jdsupra.com
California , United States , Switzerland
Updated FDA COVID-19 Guidance for Conduct of Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
Rockville , Fishers , United States
FDA Issues Guidance for Clinical Trial Sponsors and Investigators Regarding Impact of COVID-19 on Clinical Trials jdsupra.com
California , United States , Switzerland
Clinical research flexibilities during the COVID-19 public health emergency jdsupra.com
California , United States , Switzerland
EDPB’s New Guidelines – Clinical Trials in the EU and COVID-19 jdsupra.com
California , United States , Switzerland
Europe Update – Life Sciences Products and COVID-19: From Clinical Trials to Regulatory Flexibility jdsupra.com
California , United States , Switzerland , Europe
NLRA Considerations During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Clarifying Wage Payments during COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
Cybersecurity Risks Increasing During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland